Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
NMRA holding history
Neumora Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NMRA overviewAll 13F holders of NMRAFull Q2 2026 holdings
- Shares (Q2 2026)
- 828,933
- Value
- $1.41M
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 828,933 | $1.41M | <0.1% | +485,347+141.3% | Added | Holders |
| Q1 2026 | 343,586 | $670.0K | <0.1% | −162,217−32.1% | Reduced | Holders |
| Q4 2025 | 505,803 | $905.4K | <0.1% | +505,803 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −17,187−100.0% | Sold out | Holders |
| Q2 2025 | 17,187 | $12.6K | <0.1% | +17,187 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −144,769−100.0% | Sold out | Holders |
| Q4 2024 | 144,769 | $1.53M | <0.1% | +144,699+206,712.9% | Added | Holders |
| Q3 2024 | 70 | $925 | <0.1% | −860,373−100.0% | Reduced | Holders |
| Q2 2024 | 860,443 | $8.46M | <0.1% | −963,540−52.8% | Reduced | Holders |
| Q1 2024 | 1,823,983 | $25.1M | <0.1% | −19,308−1.0% | Reduced | Holders |
| Q4 2023 | 1,843,291 | $30.3M | <0.1% | −325,227−15.0% | Reduced | Holders |
| Q3 2023 | 2,168,518 | $29.7M | <0.1% | +2,168,518 | New | Holders |